NCT01468610View on ClinicalTrials.gov

Neurocognition and Work Productivity in Major Depressive Disorder (MDD)

NACompletedINTERVENTIONAL
Enrollment

47

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

September 30, 2014

Study Completion Date

December 31, 2014

Conditions
Major Depressive Disorder
Interventions
DRUG

desvenlafaxine

50-100 mg daily for 8 weeks

Trial Locations (1)

V6T 2A1

University of British Columbia, Department of Psychiatry, Vancouver

Sponsors

Collaborators (1)

Pfizer
All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

University of British Columbia

OTHER

NCT01468610 - Neurocognition and Work Productivity in Major Depressive Disorder (MDD) | Biotech Hunter | Biotech Hunter